Trial intelligence / Profile preview

Promethazine vs. Lorazepam for Treatment of Vertigo in the Emergency Department

NCT01827293Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2013
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of promethazine, lorazepam in Peripheral vertigo, sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2013; status: completed.

02

Drugs

promethazinelorazepam
03

Conditions

Peripheral vertigo

Beyond the preview

Go deeper on NCT01827293.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01827293.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call